Document is current

Article History

Received: 27 August 2025

Accepted: 5 October 2025

First Online: 1 November 2025

Declarations

:

: All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was evaluated by the first author’s Institutional Review Board.

: For this type of study formal consent is not required.

: CK serves as consultant for Acandis GmbH (Pforzheim, Germany) and as proctor for MicroVention Inc./Sequent Medical (Aliso Viejo, CA, USA). TL serves or previously served as proctor for MicroVention Inc./Sequent Medical (Aliso Viejo, CA, USA), CERUS Endovascular (Fremont, CA, USA), Phenox (Bochum, Germany), Stryker (Kalamazoo, MI, USA), and Medtronic (Dublin, Ireland). DZ is on the speaker’s bureau of Philips (Amsterdam, the Netherlands) and lecturer for Amboss GmbH (Cologne, Germany). FD serves as consultant/proctor for MicroVention Inc./Sequent Medical (Aliso Viejo, CA, USA), Balt (Irvine, CA, USA), Cerenovus/Johnson&Johnson (Irvine, CA, USA); received speakers honoraria from Cerenovus/Johnson&Johnson (Irvine, CA, USA), Acandis (Pforzheim, Germany), Asahi (Tokyo, Japan), Q`Apel (Fremont, CA, USA), Penumbra (Alameda, CA, USA), Medtronic (Dublin, Ireland), Stryker (Kalamazoo, MI, USA); received scientific grants from Cerenovus/Johnson&Johnson (Irvine, CA, USA).